<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04437173</url>
  </required_header>
  <id_info>
    <org_study_id>1480456-1</org_study_id>
    <nct_id>NCT04437173</nct_id>
  </id_info>
  <brief_title>Pain Procedures and Anxiolysis Via Distraction With Virtual Reality</brief_title>
  <acronym>PAIN-VR</acronym>
  <official_title>Immersive Audiovisual Distraction With Virtual Reality (VR) to Reduce Anxiety and Sedation Requirements During Pain Procedures in the Interventional Pain Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Davis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of VR distraction on reducing anxiety
      patients undergoing interventional pain procedures compared to placebo/active placebo or a
      non VR option.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety Score</measure>
    <time_frame>Immediately before procedure and immediately after procedure.</time_frame>
    <description>State-Trait Anxiety Inventory (Self-reported anxiety instrument containing two separate 2-item subscales that measure trait (baseline) and state (situational) anxiety; Total range 20 to 80 with higher scores indicating greater anxiety)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Score</measure>
    <time_frame>Immediately before procedure, during procedure, and immediately after procedure</time_frame>
    <description>Pain score on an 11-point numerical rating scale (Total range 0-10 with higher scores indicating greater pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation Requirements</measure>
    <time_frame>During course of procedure</time_frame>
    <description>Amount of benzodiazepines and opioid medications given</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Impression of Change</measure>
    <time_frame>Immediately after procedure</time_frame>
    <description>Global Impression of Change on a 7-point scale (Lower scores indicating decline in clinical status, and higher scores indicating improvement in clinical status)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Experience Satisfaction</measure>
    <time_frame>Immediately after procedure</time_frame>
    <description>Experience Satisfaction on an 11-point scale (Total range 0-10 with higher scores indicating higher patient experience satisfaction)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Virtual Reality</condition>
  <condition>Anxiety</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Virtual Reality Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergo interventional pain procedure with virtual reality distraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention Arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients undergo interventional pain procedure without virtual reality distraction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual Reality Headset Distraction</intervention_name>
    <description>Patient wears a virtual reality headset during interventional pain procedure</description>
    <arm_group_label>Virtual Reality Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged over 18 years old, who are referred to University of California Davis
             Pain Medicine Clinic and require an interventional pain procedure

          -  English speaking

          -  Having the ability to understand oral and written instructions

          -  Willing to fill out psychometric surveys.

        Exclusion Criteria:

          -  Pregnant women

          -  Prisoners

          -  Patients who have high risk of motion sickness, seizure disorder, or visual/hearing
             impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naileshni Singh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Sun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Jung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Naileshni Singh, MD</last_name>
    <phone>916-734-5031</phone>
    <email>naisingh@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>John Sun, MD</last_name>
    <phone>916-816-2811</phone>
    <email>johsun@ucdavis.edu</email>
  </overall_contact_backup>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 18, 2020</study_first_posted>
  <last_update_submitted>June 16, 2020</last_update_submitted>
  <last_update_submitted_qc>June 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

